Cancer Death Rates Vary Across Congressional Districts
Cancer death rates in the US have declined in recent years, but the declines vary by congressional district, a study suggests.
Cancer death rates in the US have declined in recent years, but the declines vary by congressional district, a study suggests.
Investigators report results from the phase 3 randomized EMBARK trial.
Findings suggest link to more aggressive disease among estrogen users, but researchers say larger studies needed.
Investigators analyzed survey results from 495 patients with newly diagnosed localized prostate cancer.
A recent study found a racial disparity in the use of guideline-concordant treatment for metastatic prostate cancer.
Patients with localized prostate cancer have similar cancer-specific mortality whether they undergo surveillance, surgery, or radiotherapy, a study suggests.
Combining camonsertib with PARP inhibitors may be an effective strategy for treating advanced solid tumors, a study suggests.
Researchers say they have identified 4 subtypes of prostate cancer with distinct biological and clinical features, and these subtypes may respond differently to treatment.
Stronger diet effect seen in Gleason grade group >6 and in International Society of Urological Pathology grade 3 + 4 + 5 tumors.
Adding MDT to intermittent hormone therapy improves disease control in oligometastatic prostate cancer, a phase 2 trial suggests.